KRTX - Karuna Therapeutics, Inc.

QQQ $ 422.58 $ -3.07 (-0.72 %)

DIA $ 378.81 $ 0.76 (0.2 %)

SPY $ 500.35 $ -1.63 (-0.32 %)

TLT $ 88.50 $ 0.65 (0.74 %)

GLD $ 213.80 $ 1.92 (0.91 %)

Previous Close

$ 329.83

Open

$ 329.97

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 329.75 - $ 329.97

52 Week Range

$ 158.38 - $ 329.99

Volume

1,868,526

Average Volume

Market Cap

12.19B

Beta (5Y Monthly)

$ 0.99

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-22-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-04-2023	03-31-2023	10-Q
5	02-23-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-08-2022	06-30-2022	10-Q
8	05-05-2022	03-31-2022	10-Q
9	02-24-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-05-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	03-24-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Neutral on K...
03/14/2024 13:31:16

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Karuna Therapeutics (NASDAQ:KRTX) with a Neutral and maintains ...

HC Wainwright & Co. Reiterates Neutral on ...
03/11/2024 11:25:19

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Karuna Therapeutics (NASDAQ:KRTX) with a Neutral and maintains...

beyond-tech-and-ai-why-the-sector-hedge-funds-prefer-is-not-the-one-youd-expect

Beyond Tech And AI: Why The Sector Hedge F...
02/27/2024 17:34:12

Hedge funds are shifting towards stability and value by favoring the health care sector over booming tech stocks.

Karuna Therapeutics: Q4 Earnings Insights
02/22/2024 13:20:19

Karuna Therapeutics Q4 EPS $(3.01) Misses ...
02/22/2024 11:33:53

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(3.01) per share which missed the analyst consensus estimate of...

Cantor Fitzgerald Reiterates Neutral on Ka...
02/20/2024 17:38:38

Cantor Fitzgerald analyst Charles Duncan reiterates Karuna Therapeutics (NASDAQ:KRTX) with a Neutral and maintains $330 pric...

this-analyst-is-bullish-on-biohavens-approach-in-neuro-psych-space

This Analyst Is Bullish On Biohaven's Appr...
02/16/2024 18:58:46

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion acro...

ubs-bullish-on-this-depression-drug-maker-says-alzheimers-agitation-data-is-attractive-catalyst

UBS Bullish On This Depression Drug Maker,...
02/06/2024 19:19:39

UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. P...

Mizuho Downgrades Karuna Therapeutics: Her...
01/26/2024 17:00:10

Mizuho Downgrades Karuna Therapeutics to N...
01/26/2024 10:59:22

Mizuho analyst Vamil Divan downgrades Karuna Therapeutics (NASDAQ:KRTX) from Buy to Neutral and raises the price target from...

Cantor Fitzgerald Reiterates Neutral on Ka...
01/17/2024 16:26:51

Cantor Fitzgerald analyst Charles Duncan reiterates Karuna Therapeutics (NASDAQ:KRTX) with a Neutral and maintains $330 pric...

5-biotech-stocks-that-should-be-on-investors-radar-as-jpmorgan-healthcare-conference-gets-underway-monday

5 Biotech Stocks That Should Be On Investo...
01/08/2024 11:04:30

The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even ...

Microsoft To Rally Over 20%? Here Are 10 T...
12/28/2023 13:35:57

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

JP Morgan Downgrades Karuna Therapeutics t...
12/28/2023 10:24:52

JP Morgan analyst Jessica Fye downgrades Karuna Therapeutics (NASDAQ:KRTX) from Overweight to Neutral and raises the price t...

bristol-myers-acquisition-of-karuna-therapeutics-paves-way-for-aggressive-global-marketing-of-karxt-analyst

Bristol-Myers' Acquisition Of Karuna Thera...
12/26/2023 19:02:48

H.C.

cognizant-technology-solutions-to-rally-over-13-here-are-10-top-analyst-forecasts-for-tuesday

Cognizant Technology Solutions To Rally Ov...
12/26/2023 13:03:37

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

HC Wainwright & Co. Downgrades Karuna Ther...
12/26/2023 11:14:59

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Karuna Therapeutics (NASDAQ:KRTX) from Buy to Neutral and rais...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
12/25/2023 17:30:49

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
12/25/2023 13:05:52

Dow Edges Lower; Nike Sales Miss Estimates
12/22/2023 19:47:48

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Friday. The Dow traded down 0.05...